Search

everythinglearnresearchcommunity

for

Search:↓

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Choose treatments for sex offenders based on individual needs, using hormonal and nonhormonal options to reduce sexual drive.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Monitoring for adverse effects in clinical treatments is crucial.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Elagolix did not effectively treat polycystic ovary syndrome.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Removing both ovaries treated the woman's excess male hormone symptoms.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.